Medical System Network (4350) · RiskRestated
Risk of failing to meet implementation targets due to a decline in LINE users or service suspension
First written in FY2021. 1 of 2 entries say "Restated". Latest entry: FY2022.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
LINE business risks related to the user base, monetisation and overseas expansionA theme 2 companies write about · 2 as a headwind · 0 as a tailwind
1 other company's latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「If the introduction of the service at pharmacies does not progress as planned due to a decline in the number of LINE users, suspension of LINE services, or other factors, this could affect the performance of the Group.」
The risk of failing to meet implementation targets due to a decline in LINE users or service suspension continues to be reported. - FY2021First statedAnnual report
「If the introduction of the service at pharmacies does not progress as planned due to a decline in the number of LINE users, suspension of LINE services, or other factors, this could affect the performance of the Group.」
A new risk has been reported that the introduction at pharmacies of the service supporting the conversion to patients' regular pharmacies may not progress as planned due to a decline in the number of LINE users or service suspension.